Major depressive disorder remains one of the leading causes of disability worldwide, affecting an estimated 280 million people across all age groups and income levels. Structural gaps in prevention, diagnosis, and treatment continue to drive this burden, and the World Federation for Mental Health (WFMH) has identified inadequate service coverage as a central obstacle to meaningful progress.
According to the World Health Organization’s World Mental Health Report 2022, depression accounts for approximately 7.5% of all years lived with disability globally. Only 29% of people with depression in high-income countries receive minimally adequate treatment — a figure that falls dramatically in low- and middle-income settings, where access to care remains severely limited.
The World Federation for Mental Health advocates for the integration of depression screening and treatment into primary health care systems as a cost-effective strategy for closing the treatment gap. Position papers published by WFMH have consistently emphasized that untreated depression generates substantial economic costs through reduced productivity, increased absenteeism, and premature mortality.
Evidence published in The Lancet Psychiatry (2021) has reinforced the biological and psychosocial complexity of depression, underscoring the need for stepped-care models that combine pharmacological, psychological, and social interventions. The World Federation for Mental Health supports the global adoption of such integrated frameworks, with particular urgency in post-conflict and low-resource settings.
Depression cannot be addressed in isolation from poverty, gender inequality, and social exclusion. WFMH global advocacy aligns with the targets outlined in the WHO Comprehensive Mental Health Action Plan 2013–2030, which calls for a 50% improvement in access to mental health care for severe mental disorders by 2030. Achieving this goal requires immediate and sustained investment at the national and international levels.